Tks. Anjo, Celgene are prolific dealmakers , this may explain somewhat .......................
"Under the deal, the pair will split development costs and eventual profits down the middle, with Celgene handling global sales while Agios runs the books in the U.S.
The arrangement marks the third tie up between the two companies, broadening a relationship that began in 2010 with a $120 million deal for the cancer-treating AG-221. The pair have since teamed up on AG-120, which also targets tumors with so-called IDH mutations, plotting to get both into pivotal studies over the next two years." It is a very complex relationship ....The proposed deal between Celegne And MSB .if it takes longer to come to fruition the better for MSB I would hope for it to be anned .. early next week .....V
..
Tks. Anjo, Celgene are prolific dealmakers , this may explain...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |